Phase III study of aldoxorubicin vs investigators' choice as treatment for relapsed/refractory soft tissue sarcomas

Category Primary study
JournalJournal of Clinical Oncology
Year 2017
This article has no abstract
Epistemonikos ID: be00c54e8c3b9de4c9a6051206bd352d81577022
First added on: Feb 08, 2025